Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
This health news summary explores various pharmaceutical developments including Novo Nordisk's phasing out of insulin pens, a ...
Novo Nordisk (NVO) reportedly plans to phase out production of its human insulin pens while it ramps up production of other ...
Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...
Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...
A study of Gila monster venom helped start the revolution in weight-loss drugs. But scientists think that’s just the ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
NEW ORLEANS (WVUE) - If you have trouble affording prescription drugs, some independent pharmacists say that so-called ...
Obesity causes insulin resistance by increasing activation of the sympathetic nervous system and the release of the stress hormone norepinephrine, according to a new study.
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback